Answers are grounded in this paper and cite their sources.
Introduction Irreversible electroporation (IRE) has emerged as a promising nonthermal ablation technique for the treatment of malignant tumors.[1–3] By applying high-voltage electrical pulses to tumor tissue, IRE creates irrecoverable pores in the cell membrane, thus disrupting the balance between the intracellular and extracellular environments, and ultimately causing cell death.[1] This technique offers several advantages over traditional thermal ablation methods, including no heat sink effect, a clear display of the ablation area, and preservation of adjacent blood vessels and nerves.[4,5] The present review discusses the current research status, hotspots, controversies, and future directions of IRE in the treatment of malignancies. 2. Current research status 2.1. Mechanism of IRE IRE involves the application of high-voltage electrical pulses to the tumor tissue, which creates irrecoverable pores in the phospholipid bilayer of the cell membrane. These pores disrupt the balance between the intracellular and extracellular environments, thereby leading to cell death. Previous studies have shown that IRE can effectively ablate tumor tissues without causing significant damage to adjacent structures.[1,2] 2.2. Advantages of IRE IRE offers several advantages over the traditional thermal ablation methods.[6] First, it carries no heat sink effect, which means that the ablation area can be clearly displayed without interference from the surrounding tissues. Second, IRE preserves the adjacent blood vessels and nerves, reducing the risk of complications such as bleeding and nerve damage. Third, IRE has is effective in treating tumors that are resistant to other ablation techniques, such as those located near vital structures or those with a high degree of vascularization. 2.3. Clinical applications of IRE IRE has been used to treat various malignant tumors, including liver,[2,7] prostate,[8-11] pancreas,[12–16] breast,[17] and colorectal cancer.[18] Clinical studies have shown that IRE achieves good ablation effects with low complication rates. 3. Research hotspots 3.1. Combination therapy with IRE One of the current research hotspots in the field of IRE is the combination of IRE with other treatment modalities such as chemotherapy and immunotherapy. Previous studies have shown that the combination of IRE and chemotherapy can enhance the antitumor effects and reduce the risk of recurrence. In addition, IRE stimulates the immune system, making it a potential candidate for combination immunotherapy.[5] 3.2. Development of novel IRE equipment and techniques Another research hotspot is the development of novel IRE equipment and techniques to improve the treatment efficacy and safety. For example, the use of magnetic anchoring electrodes and robotic systems has been explored to improve the accuracy and repeatability of IRE. In addition, research is ongoing to develop novel pulse parameters and ablation protocols to optimize treatment outcomes. 4. Controversies 4.1. Efficacy of IRE in specific tumor types Despite the promising results of IRE in the treatment of various malignant tumors, its efficacy in certain tumor types remains controversial. A recent clinical trial in patients with lung cancer showed that IRE was ineffective in treating primary lung cancer or malignant lung metastases.[19] It was speculated that the presence of air in the alveoli may have interfered with energy absorption between the IRE electrodes, therefore leading to incomplete ablation.[20] 4.2. Risk of recurrence A follow-up study including 123 patients treated with IRE for prostate cancer (PCa) showed a 14.6% recurrence rate within 12 months,[8] despite 98.8% maintenance of urinary continence and 76% patients reporting stable erectile function. In addition, a European multicenter study comparing focal and extended ablations in 106 patients with PCa showed recurrence rates of 18.8% and 13.2%, respectively, at 30 months,[21] with no severe adverse events. Although IRE preserves urinary and sexual functions, its tumor control efficacy is limited by tumor heterogeneity and residual cells owing to electric field diffraction. A nationwide multicenter study[22] conducted in Sweden assessed the short- and long-term outcomes of IRE in the treatment of hepatocellular carcinoma (HCC) and colorectal cancer liver metastases (CRCLM). The median overall survival was 27.0 months for patients with CRCLM and 35.0 months for patients with HCC. Despite the occurrence of severe complications in only 3 cases (2.0%), the local ablation success rates for HCC at 6 and 12 months were only 58.3% and 40.3%, respectively, and for CRCLM, the success rates were 37.7% and 25.4%, respectively. Therefore, further research is required to develop techniques to reduce the risk of recurrence and improve patient safety. 5. Future directions 5.1. Optimization of IRE parameters and protocols Future research should focus on optimizing the IRE parameters and protocols to improve treatment efficacy and safety. This may involve exploring novel pulse parameters, electrode configurations, and ablation protocols to achieve better tumor control and reduce the risk of complications. 5.2. Development of novel IRE applications Significant advancements in the development of novel applications for IRE have been made, and its uses have expanded beyond traditional cancer treatments. Various innovative uses of IRE have been explored in multiple studies with the purpose of addressing medical challenges across various specialties. 5.3. Advancements in cancer treatment One of the most promising areas for IRE development is the treatment of various types of cancer. Early research has focused on liver, pancreatic, and prostate cancers; however, recent studies have explored the use of IRE in other malignancies. For example, the use of IRE in combination with immunotherapy to enhance treatment outcomes has been investigated. By inducing immunogenic cell death, IRE can stimulate the immune system to attack residual tumor cells, thus potentially reducing the risk of recurrence and metastasis.[16,22] Furthermore, the development of advanced IRE devices and electrodes has enabled more precise and effective treatments. For example, the introduction of thermally controlled electrodes has allowed for better control of thermal effects during ablation, thereby leading to more consistent treatment outcomes. Similarly, the design of novel electrode configurations such as magnetically anchored catheters and suction cup electrodes,[23] has improved the accessibility and stability of IRE treatments in difficult-to-reach tissues. 5.4. Noncancer applications IRE technology has also been explored for noncancer applications. One such area is the treatment of benign tumors and cysts.[24,25] IRE offers a minimally invasive alternative to traditional surgical excision with the potential to decrease postoperative pain, shorten recovery time, and reduce complications. Researchers have also investigated the use of IRE in regenerative medicine. By precisely controlling the electrical parameters,[24] IRE can be used to induce specific cellular responses, such as the release of growth factors or the activation of stem cells. These responses can be harnessed to promote tissue regeneration and healing in various medical conditions. 6. Conclusion The development of novel IRE applications is a promising area of research with the potential to transform the treatment of various medical conditions. With continued innovation and interdisciplinary collaboration, we expect to see the expansion of IRE technology into new fields, leading to improved patient outcomes and more effective combined treatments.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: